| Literature DB >> 34104185 |
Saida Abrar1, Raheela Mohsin Rizvi2, Nida Zahid3.
Abstract
OBJECTIVES: This study asseses the association of overactive bladder symptoms and pelvic organ prolapse severity and evaluates the effect of pelvic reconstructive surgery on overactive bladder (OAB) symptoms in women with pelvic organ prolapse (POP). It also looks into any pre and post-operative factors responsible for persistent postoperative OAB symptoms.Entities:
Keywords: Overactive bladder (OAB); Pelvic organ prolapse (POP); Pelvic organ prolapse surgery
Year: 2021 PMID: 34104185 PMCID: PMC8155413 DOI: 10.12669/pjms.37.3.3312
Source DB: PubMed Journal: Pak J Med Sci ISSN: 1681-715X Impact factor: 1.088
Baseline Characteristics of patients with Pelvic organ prolapse.
| Pelvic organ prolapse (Stage 1 and 2) (n=72) | Pelvic organ prolapse (Stage 3 and 4) (n=63) | p-value | |
|---|---|---|---|
| Age (years) (Mean±SD) | 55.67 (9.82) | 62.108 (10.54) | <0.001 |
| Parity (median (IQR)) | 4 (3-5) | 4(3-5) | 0.813 |
| BMI (kg/m2) (median(IQR)) | 26.5 (23.6-32) | 25. 4(23.6-31.6) | 0.637 |
| Duration of symptoms (months) (median (IQR)) | 10 (8-12) | 12 (8-12) | 0.338 |
| No | 49 (80.3%) | 53 (71.6%) | 0.241 |
| Yes | 12 (19.7%) | 18 (28.4%) | |
| No | 31 (50.8%) | 41 (55.4%) | |
| Yes | 30 (49.2%) | 33 (44.6%) | 0.595 |
| 0.552 | |||
| No | 27 (44.3%) | 29 (39.2%) | |
| Yes | 34 (55.7%) | 45 (60.8%) | |
| No | 41 (67.2%) | 43 (58.1%) | |
| Yes | 20(32.8%) | 31 (41.9%) | 0.278 |
| No | 58 (95.1%) | 67 (90.5%) | 0.511 |
| Yes | 3 (4.9%) | 7 (9.5%) | |
| Aa point (cm) (median (IQR)) | 1 | 6 (3-7) | <0.001 |
| Ba- point(cm) (median (IQR)) | 1 | 6 (4-7) | <0.001 |
| Ap point (cm) (median (IQR)) | 0 (0-1) | 4 (2-7) | <0.01 |
| Bp point (cm) (median (IQR)) | 0 (0-1) | 4 (2-7) | <0.001 |
| C point (cm) (median (IQR)) | 1 (0-1) | 5 (2-7) | <0.001 |
| D point (cm) (median (IQR)) | 8 | 6 (4-8) | <0.001 |
Data are mean±standard deviation, median ( interquartile range (IQR)) or number (%), Body Mass Index, Hypertension, Diabetes mellitus,
significant at p-value <0.05 by using Independent t-test / Mann whitney U test
Comparison of changes in the overactive bladder symptoms in both groups of POP before and after surgery.
| Preoperative | Postoperative | P-value | |||
|---|---|---|---|---|---|
| Frequency | 2(2-3) | 1±1-2 | 1(1-2) | 1±0.00 | 0.001 |
| Urge incontinence | 2(2-3) | 1±1-2 | 1(1-2) | 0.001 | |
Data are median ( interquartile range (IQR)); Data was defined by Pelvic Floor Distress Inventory item no. 15 (frequency) and item no. 16 (urge incontinence
significant at p value < 0.05 by using wilcoxin sign rank test
Overactive bladder symptoms before and after surgery.
| POP stage 1 and 2 (n=72) | POP stage 3 and 4 (n=63) | P-value | |
|---|---|---|---|
| Improvement | 28 (45.9%) | 35 (47.3%) | |
| Resolution | 7 (11.5%) | 8 (10.8%) | 0.757 |
| Persistence | 14 (23.0%) | 21 (28.4%) | |
| Worsen | 12 (19.7%) | 10 (13.5%) | |
| Improvement | 26 (42.6%) | 37 (50.0%) | |
| Resolution | 14 (23.0%) | 16 (21.6%) | |
| Persistence | 18 (29.5%) | 16 (21.6%) | 0.707 |
| Worsen | 3 (4.9%) | 5 (6.8%) |
Data are number (%).POP-pelvic organ prolapse. Urinary frequency defined by Pelvic Floor Distress Inventory item no. 15; urge incontinence defined by Pelvic Floor Distress Inventory item no. 16.
Pre and postoperative factors related to persistence and worsening of overactive bladder symptoms after POP repair.
| Frequency (n=78) | Urge incontinence (n=57) | |||||
|---|---|---|---|---|---|---|
| Improvement[ | Persistence[ | p-value | Improvement n=98 (72.6%) | Persistence n=37 (27.4 %) | p-value | |
| Age (yr) Mean ±SD | 60 ± 10 | 57.9 ± 10 | 0.233 | 58.87 ± 11 | 60.05 ± 9.8 | 0.570 |
| Parity Median (IQR) | 4 (3-6) | 4 (3-5) | 0.28 | 4 (3-5) | 5 (3-6) | 0.139 |
| Ba point (cm) Median (IQR) | 2 (1-6) | 2 (1-6) | 0.758 | 2 (1-6) | 1 (1-5) | 0.151 |
| Bp point (cm) Median (IQR) | 1 (0.0-4) | 1 (0.0-4) | 0.886 | 1 (0.0-4) | 1 (0.0-3.5) | 0.122 |
| C point Median (IQR) | 1 (0.0-4) | 1 (0.0.4.5) | 0.829 | 1.50 (1-6) | 1 (0.0-4) | 0.181 |
| BMI (kg/m2) Median (IQR) | 25 (24-28) | 30.7(24-35) | 0.003 | 25.4 (24-29) | 31.2 (25-37) | 0.001 |
| Stage 1 and 2 | 35 (44.9%) | 26 (45.6%) | 0.932 | 40 (40.8%) | 21 (56.8%) | 0.097 |
| Stage 3 and 4 | 43 (55.1%) | 31 (54.4%) | 58 (59.2%) | 16 (43.2%) | ||
| Yes | 41 (52.6%) | 26 (45.6%) | 0.425 | 42 (42.9%) | 26 (70.3%) | 0.004 |
| No | 37 (47.4%) | 31 (54.4%) | 56 (57.1%) | 11 (29.7%) | ||
Data are mean ± standard deviation, median (IQR) or number (%).
Women with resolution of symptoms were included in the improvement group
Women with worsening of symptoms were included in the persistence group. POP- pelvic organ prolapse; BMI-body mass index,
significant at p value < 0.05 by using Mann whitney U test,
significant at p value < 0.05 by using chi-square test